Investment
Features
FeesSafety
Academy
More
Pluang+

Card Factory keeps full-year profit forecast as sales rise despite weaker UK store trade

Company Fundamentals
29 Sep 2026
Proactive Investors
View Source
Neutral
Card Factory keeps full-year profit forecast as sales rise despite weaker UK store trade

Card Factory reported a 5.3% revenue increase to £260.8 million in the first half, maintaining its full-year profit forecast despite weaker UK store sales. Adjusted profit before tax fell slightly by 3.8% to £12.7 million due to investments in digital and international growth, while statutory profit before tax rose 63.4% to £12.3 million. Digital sales grew following the Funky Pigeon acquisition, and wholesale sales increased by 13.6%, with expected synergies on track for 2028. The company remains confident in its outlook, supported by improved UK like-for-like sales and strong trading in Ireland, with a focus on the second half and Christmas period.

Card Factory's recent performance is presented with Pluang's Consumer Cyclical sector data as of Sep 29, 2026 14:01 WIB. Among 112 US stocks in this sector, 34 rose and 67 fell today. Notable movers include Gogoro Inc (GGR) at USD 3.23 with a 5.90% increase and 100% sell order activity, Gap Inc (GAP) at USD 22.94 up 5.13% with 74% buy orders, and Advance Auto Parts, Inc. (AAP) at USD 39.77 down 4.70% with 100% buy orders. The most notable figure is Gogoro Inc's 5.90% price increase.

More News

New Ethereum Fast Confirmation Rules cut cross-chain transaction times from 13 minutes to seconds.

New Ethereum Fast Confirmation Rules cut cross-chain transaction times from 13 minutes to seconds.

Ethlabs has integrated Ethereum Fast Confirmation Rules (FCR) with Chainlink's CCIP 2.0 to speed up Ethereum confirmation times in certain cross-chain transactions. This system uses validator consensus to provide an early confirmation signal, reducin...

Protocol Fundamentals
Bullish
4 hours ago
AstraZeneca invests $2B in Summit Therapeutics for cancer drug collaboration and trials

AstraZeneca invests $2B in Summit Therapeutics for cancer drug collaboration and trials

AstraZeneca is investing $2 billion in Summit Therapeutics to collaborate on cancer drug development, acquiring about 12% of Summit's common stock. The partnership will start clinical trials combining Summit’s ivonescimab with AstraZeneca’s sonesitat...

Market News
Bullish
4 hours ago
Bitwise's Solana Staking ETF buys $9.65M SOL, dominating US spot Solana ETF inflows with 80% market share.

Bitwise's Solana Staking ETF buys $9.65M SOL, dominating US spot Solana ETF inflows with 80% market share.

Bitwise's Solana Staking ETF (BSOL) recently purchased $9.65 million worth of Solana (SOL) tokens on the open market, contributing to a total of approximately $948 million in cumulative SOL purchases since its launch in October 2025. BSOL dominates t...

Market News
Bullish
4 hours ago
IBM shares fall 16% since June but no fundamental issues seen, potential for value growth remains.

IBM shares fall 16% since June but no fundamental issues seen, potential for value growth remains.

IBM's stock has dropped about 16% since mid-June, significantly underperforming the market. Despite this decline, there are no structural problems identified with the company. Strong institutional demand and undervaluation suggest that IBM could see ...

Market News
Neutral
4 hours ago
Bitcoin's recent rally shows 19% less profit-taking than August peak, signaling cautious investor behavior.

Bitcoin's recent rally shows 19% less profit-taking than August peak, signaling cautious investor behavior.

Bitcoin's realized profit during its recent peak on September 24 was $7.3 billion, 19% lower than the $9.1 billion recorded at the August 26 peak. Realized losses also dropped from $2.6 billion to $1.5 billion between these periods. The short-term ho...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App